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SUMMARY: Several animal model studies have shown that Diabetes mellitus can affect on the activity of hippocampus astrocytes,
but these studies reported controversial findings. This study was done to evaluate the preventive and treatment effect of Urtica dioica (U.
dioica) on astrocytes density in the CA1 and CA3 subfields of hippocampus of streptozotocin (STZ) induced diabetic rats. Twenty-eight
male albino Wistar rats were randomly allocated equally into control, diabetic, U. dioica treatment and U. dioica preventive groups.
Hyperglycemia was induced by STZ (80 mg/kg/BW). One week after injection of the streptozotocin, animals in treatment group were
received  hydroalcoholic extract of U. dioica (100 mg/kg/BW /day) for 4 weeks by intraperitoneally. In preventive group, diabetic rats were
received 100 mg/kg/BW/ daily hydroalcoholic extract of U. dioica for 5 days before STZ injection. Then, animals were sacrificed and
coronal sections were taken from the right dorsal hippocampus, stained with PTAH. The area densities of the astrocytes were measured. The
number of astrocytes in CA1 of controls, diabetic treatment and preventive groups was 19.00±5.5, 17.14±6.4, 21±8.1 and 16.48±3.2,
respectively. The densities of astrocytes in CA3 of controls, diabetic, treatment and preventive groups were 25.45±7.60, 21.54±7.5, 23.75±5.6
and 19.89±3.8, respectively. The density of astrocytes in diabetic rats reduced in comparison with controls (P<0.05). In CA1 and CA3, in
spite of preventive administration, treatment of diabetic rats with U. dioica significantly increased the astrocytes. This study showed that
treatment with U. dioica extract can help compensate for the CA1 and CA3 subfields of hippocampus astrocytes in diabetic rats.
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INTRODUCTION
Diabetes mellitus is one of the most common serious
metabolic disorders (Gispen & Biessels, 2000). Diabetes
mellitus causes a variety of functional and structural
alterations including hippocampal astrogliosis (Saravia et
al., 2002), decreased hippocampal synaptic plasticity,
neurotoxicity and changes in glutamate neurotransmission
(Revsin et al., 2005) of the central nervous system.
Astrocytes as glial cells in the central nervous system
are effective in Supporting of neurons, scar formation and
maintenance of the blood–brain barrier (Afsari et al., 2008),
vascular reactivity, regulation of extracellular glutamate
levels, energy metabolism, and protection from reactive
oxygen species (Dringen et al., 2000; Tsacopoulos &
Magistretti, 1996; Zonta et al., 2003).
Several animal model studies reported that Diabetes
mellitus can affect on the activity of hippocampus astrocytes,
but these studies reported controversial findings. some
researches indicated that diabetes led to increasing of
astrocytes (Saravia et al.; Baydas et al., 2003a, 2003b; Revsin
et al.), but other studies  have  shown that diabetes mellitus
reduced  the  number and activity of astrocytes (Coleman et
al., 2004; Coleman et al., 2010).
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Furthermore, several studies indicated that induction
diabetes is associated with a reduction in GFAP-positive
astrocytes in the spinal cord and death of hypothalamic
astrocytes in poorly controlled diabetic rats (García-Cáceres
et al., 2008; Afsari et al.).
In recent years, there has been renewed interest in
plant medicine for the treatment of different diseases
(Kameswara Rao et al., 2003; Ladeji et al., 2003). Isolated
studies screened various plants having “folk medicine
reputation” by biochemical test for this antidiabetogenic
effect (Vats et al., 2002).
Urtica dioica L. Stinging nettle (Urticacea) is annual
and perennial herb, distinguished with stinging hairs
(Kavalali et al., 2003). Among the Urtica species, Urtica
dioica (U. dioica) has already been known for a long time
as medicinal plants in the world. The blood sugar lowering
effect of U. dioica as a medicinal herb has been introduced
in old script such as those written by Avicenna (Farzami et
al., 2003). In addition, U. dioica is among several species
listed for their use against diabetes in folk medicine in a
large pharmacological screen of European species (Atta-Ur-
Rahman & Zaman, 1989).
Since there is controversy about the effect of Diabetes
mellitus on astrocytes alterations in the CA1 and CA3 subfields
of hippocampus and lack of study regarding the effect of Urtica
dioica on hippocampal astrocyte density, this study carried
out to evaluate  the preventive and treatment effect of U. dioica
on astrocytes density in the CA1 and CA3 subfields of
hippocampus of STZ induced diabetic rats.
MATERIAL AND METHOD
In this experimental study 28 adult male Wistar rats
(weighing 250–300 g) were used. All animals were treated
in agreement with the Helsinki Convention on the use of
animals in research approved by the Institutional Review
Board. The animals were kept in air-conditional animal room
(22± 2˚C) under a 12 h light/dark cycle.
Collection of Plant. Fresh leaves of U. dioica were collected
from cultivated plant, from suburb of Gorgan, northern Iran
(Golestan, Iran) in OCT 2005 and taxonomically identified
by Department of Pharmacognosy, Mazandaran University
of Medical Sciences. A voucher specimen (5-77-1) was
deposited in the herbarium of Mazandaran University.
Preparation of extract of Urtica dioica. The dried and
powered of U. dioica leaves (400 g) were percolated by
Ethanol (45%) solvent. In briefly the dried leaf of U. dioica
(by using hot air 35-40 ºC) powdered by mechanical milling.
Prelinering maceration during 5 hours was done and the
product percolated and mixing during 48 hours. The extract
was filtrated (0.8 Micron) and spray dried in a lab plant SD4
spray drier (lab plant ltd, England). Spectrophotometric assay
was carried out to determine the concentration of phenolic
and flavonid content of U. dioica leaves extract (Kraus &
Spiteller, 1991; Evans, 2002). Also antioxidant activity was
measured by DPPH method.
Chemical. All chemical such as Streptozotocin (STZ) used
were of analytical grade obtained from Merck and Sigma.
Experiment induction of diabetes. Streptozotocin was
dissolved in saline immediately use and intraperitoneally
injected. Diabetes was induced with a single intraperitoneally
(IP) injection of Streptozotocin (STZ) (80 mg/kg) to
overnight fast rats. Blood samples for glucose measurements
were taken from the tail vein. Diabetes was confirmed by
measuring the glucose concentration by using Glucometer
method.
Experimental design. For this study four groups designed:
Normal healthy control group (Group I), received Saline
daily for 4 weeks. Diabetic group (Group II) received Saline
daily for 4 weeks after STZ injection, Treatment group
(Group III), diabetic rats that administered 100 mg/kg/BW/
daily hydroalcoholic extract of U. dioica (Gülçin et al., 2004;
Kavalali et al.), for 4 weeks and preventive group, rats were
received 100 mg/kg/BW/ daily hydroalcoholic extract of U.
dioica for five days and then diabetes induced by STZ. In
the experiments, seven rats were used in each group.
Intraperitoneal glucose tolerance test (GTT). GTT was
performed on 16 h fasted rats using 2gram glucose /kg body
weight. In all groups, blood was collected from the animals
by tail snipping at 0, 30, 90 and 120 minutes after glucose
load. Also glucose test were performed after IP injection
STZ in 1 and 5 weeks.
Histological and Morphometric studies. After the animals
had been scarified, the brains were removed and fixed in
buffered formaldehyde 10% solution for histological
analysis. Brains were cut coronally into 7 µm slices.
Approximately 10 slices obtained from each brain. Then they
were processed and were stained with PTAH staining.
Then a photograph of each section was produced
using an Olympus BX 51 microscope and a DP 12 digital
camera under a magnification of 400. An area of 20000 µm2
was selected in the CA1 and CA3 subfields of hippocampus
in all sections. To measure the area density of the astrocytes,
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the images were transferred to the computer. Using OLYSIA
Autobioreport software, Olympus Co, the appropriate grids
were superimposed on the pictures and the cells were counted
manually.
Statistical analysis. Experimental data were evaluated using
Spss v.11.5 and one way ANOVA and expressed as Mean±
SE P< 0.05 was considered significant.
RESULTS
Phytochemical analysis of extract showed the
presence of phenolic and flavonids content, 22.8 ± 2.7 and
41.2 ± 3.1 mg/gram dry extract, respectively. Antioxidant
activity by DPPH method showed 25.5±2.2 percent of
scavenging activity.
The Glucose Tolerance Test (GTT) of the three groups
at the beginning and the 5th wk of the study are showed in
Fig. 1. As shown in Fig. 1, the GTT results of all rats were
normal at the beginning of experiment. At the end of study
control rats which have not received STZ showed a normal
GTT. In contrast, the diabetic rats which have been
undergone STZ-induced diabetes at the first day of study
showed the most profound impairment GTT. Also result of
GTT in treated group was similar to STZ-induced diabetes.
The density of astrocytes (per 20000 mm2) in CA1
and CA3 of hippocampus in control, diabetic Treatment and
preventive groups are depicted on Fig. 2.
The number of astrocytes in CA1 area of controls,
diabetic treatment and preventive groups was 19.00±5.5,
17.14±6.4, 21±8.1 and 16.48±3.2, respectively.
Fig. 1. The Glucose Tolerance
Test (GTT) of the four groups at
the beginning and the end of the
study.
Fig. 2. Astrocytes number in
CA1 and CA3 in control,
diabetic, treatment and
preventive groups (*
compared with control group,
** compared with diabetic
group, P<0.05)
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In CA1, treatment of diabetic rats with U. dioica
significantly increased the astrocytes as compared to diabetic
group, but preventive administration of U. dioica does not
alter the astrocytes density.
The densities of astrocytes in CA3 area of controls,
diabetic, treatment and preventive groups were 25.45±7.60,
21.54±7.5, 23.75±5.6 and 19.89±3.8, respectively.
In CA3, the density of astrocytes in diabetic rats
reduced as compared with controls (P<0.05). Treatment of
diabetic rats with U. dioica significantly increased the
astrocytes compared to diabetic group, but preventive
administration of U. dioica had no effect on astrocytes
density.
DISCUSSION
This study showed that astrocytes numbers were non-
significantly reduced in CA1 and significantly reduced in
CA3 in STZ induced diabetics rats. Our results is similar to
previous studies (Coleman et al., 2004, 2010) and is contrast
with others (Saravia et al.; Baydas et al., 2003a, 2003b;
Revsin et al.).
Coleman et al. (2010) reported that diabetes reduce
GFAP content in rats at 4 and 8 weeks of diabetes duration.
Also, Lebed et al. (2008) indicated that GFAP cell count in
CA1 and CA3 areas decrease in 3rd day in STZ induced
diabetic rats in comparison with controls.
Furthermore, reduction of astrocytes in spinal cord
and hypothalamus were reported in didactic animals (García-
Cáceres et al.; Afsari et al.). Reduction of astrocytes  in
diabetic animals can be due to astrocytes death by apoptosis
(García-Cáceres et al.).
Apoptotic cell death occurs In diabetes mellitus in
numerous tissues (Nishikawa & Araki, 2007; Allen et al., 2005;
Arroba et al., 2003, 2005, 2007; Lechuga-Sancho et al., 2006a,
2006b; Klein et al., 2004), with increase of glucose level (Ro-
mero et al., 2002; Anitha et al., 2006), decrease insulin or
insulin-like growth factor signaling (Ishii, 1995) or an increase
in cytokines such as TNFa (Chen & Goeddel, 2002). Because,
glial cells control the supply of glucose and its metabolites to
neurons (Pellerin et al., 2007), they are the first line of defense
against changes in glucose concentrations. Furthermore, when
glucose availability is reduced, glycogen stored in astrocytes
serves as a fuel source for neurons (Brown & Ransom, 2007).
Thus, it is possible that prolonged exposure to elevated glucose
levels underlies the increase death of astrocytes.
High glucose levels directly induce death of
different glial cell types (Xi et al., 2005; Delaney et al.,
2001). However, increased TNFa (Arroba et al., 2005),
decreased insulin (Arroba et al., 2007) or insulin growth
factor (IGF)-I (Busiguina et al., 1996), could be involved
in glial cell death.
The intracellular mechanism of the increase
astrocytes death most likely involves nuclear translocation
of AIF (apoptosis inducing factor) (García-Cáceres et al.,
2008).
Nuclear translocation of AIF is involved in caspase-
independent cell death in response to a variety of signals,
including oxidative stress, glutamate toxicity, and ischemia.
Loss of mitochondrial membrane integrity results in the
release of this factor, which can then be translocated to the
nucleus where it induces DNA fragmentation and chromatin
condensation (Krantic et al., 2007).
In other hand, several studies have reported that
increase of number of astrocytes in diabetes mellitus (Saravia
et al.; Baydas et al., 2003a, 2003b; Revsin et al.).
Baydas et al., (2003b) reported an increased GFAP
immunostaining in the hippocampus of 6 weeks after
induction of diabetes in rats in comparision with control
animals.
Also, Saravia et al., study is founded that the number
of GFAP cells significantly increase in SFZ-treated mice.
Indeed, Saravia et al., reported that the number of GFAP
astrocytes increased 3-fold in the hippocampal stratum
radiatum of STZ-diabetic female mice compared with age-
matched, vehicle-treated non diabetic controls.
Furthermore, Muranyi et al., (2006), found that the
number of GFAP-positive astrocytes significantly increase
in the hippocampus of diabetic rats. Also he reported that
the diameters of astrocytes body were found to be enlarged
and the number and foot processes length of astrocytes
were increased.
Astrocytosis is often related to neurodegenerative
diseases and aging, in which neuronal dysfunction or damage
can also accompanied (Goss et al., 1991; Magistretti &
Pellerin, 1999; Ridet et al., 1997).
The alterations of astrocytes number possibly due to
oxidative stress (Baydas et al., 2003b) and free radical
formation (Baydas et al., 2003a).
Studies have shown that hippocampus astrocytes of
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diabetic rats can changes due to melatonin and vitamin E
(Baydas et al., 2003a,b). Vitamin E as an antioxidant
agent and melatonin as a direct scavenger and indirect
antioxidant can affect on astrocytes in diabetics model
(Baydas et al., 2003a). In our study U. dioica leaves
extract increased the astrocytes number in CA1 and CA3
of diabetic rats. Also, Renno et al., (2008),reported that
diabetic rats treated with green tea showed a significant
increase in the number GFAP-immunoreactive astrocytes
in all the spinal cord gray areas as compared to water-
drinking diabetic rats.
In our previous studies, the treatment with U. dioica
extract after induction of diabetes can help to restore dia-
betes-induced granule cell and astrocytes loss in the rat
dentate gyrus (Fazeli et al., 2008; Jahanshahi et al., 2009)
In the present study, U. dioica extract (100 mg/kg/
BW daily for 4 weeks after induction of diabetes) increased
the number of astrocyte in CA1 and CA3 of STZ-induced
diabetic rats.
Neural protective properties of U. dioica extract in
the CA1 and CA3 of diabetic rats hippocampus have been
attributed to antioxidant and anti-apoptotic properties of
U. dioica (Fazeli et al., 2010). It is founded that U. dioica
contains phenolic compounds, particularly flavoniods
(Mavi et al., 2004). Flavonoids generally have antioxidant
potential (Hall & Cuppett, 1997). Indeed, in our study,
the preventive administration of U. dioica (100 mg/kg/
BW daily for 5 days before induction of diabetes could
not alter the reduction of astrocytes in CA1 and CA3 of
STZ-diabetic rats. Also, in our previous study, the
preventive administration of U. dioica extract can not help
to restore diabetes-induced astrocytes loss in the rat dentate
gyrus (Golalipour et al., 2011).
Although, neural cell death protective properties
of the extract in the CA1 and CA3 of diabetic mice
hippocampus have been attributed to antioxidant and anti-
apoptotic properties of U. dioica, but lack of effect of U.
dioica in this section of study may be due to low dosage
and short duration of this plant before induction of diabe-
tes in animals.
In conclusion, this study showed that astrocytes
density of hippocampus reduce in STZ induced diabetic
rats and U. dioica extract administration after induction
of diabetes for 4 weeks can be a beneficial treatment for
the regulation of astrocytes density in the in CA1 and CA3
of diabetic rats, but administration of U. dioica extract
before induction of diabetes can not help compensate for
astrocytes in hippocampus.
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RESUMEN: Varios estudios en modelos animales han mostrado que la diabetes mellitus puede afectar la actividad de los
astrocitos del hipocampo, pero estos resultados son controvertidos. Este estudio se realizó para evaluar el efecto preventivo y de
tratamiento de la Urtica dioica (U. dioica) en la densidad de los astrocitos en los subcampos CA1 y CA3 del hipocampo en ratas
diabéticas inducidas por estreptozotocina (STZ). Veintiocho ratas Wistar albinas macho fueron asignadas al azar por igual en grupos
control, diabético, con tratamiento  U. dioica y  preventivo con U.dioica. La hiperglucemia se indujo por STZ (80 mg/kg/peso
corporal). Una semana después, los animales del grupo tratamiento recibieron el extracto hidroalcohólico de U. dioica (100 mg/kg/
peso corporal/día) durante 4 semanas vía intraperitoneal. El grupo preventivo, recibió 100 mg/kg/peso corporal/día de extracto
hidroalcohólico U. dioica durante 5 días antes de la inyección de STZ. Los animales fueron sacrificados, se tomaron secciones
coronales del hipocampo dorsal derecho y se tiñeron con PTAH. Fueron medidas las densidades de área de los astrocitos. El número
de astrocitos en CA1 de los grupos de ratas control, diabéticas, con tratamiento de U. dioica y preventivo con U. dioica fue 19,00±5,5,
17,14±6,4, 21±8,1 y 16,48±3,2, respectivamente. Las densidades de los astrocitos en CA3 de los grupos de ratas control, diabéticas,
con tratamiento de U. dioica y preventivo con U. dioica fue 25,45±7,60, 21,54±7,5, 23,75±5,6 y 19,89±3,8, respectivamente. La
densidad de los astrocitos en las ratas diabéticas se redujo en comparación con los controles (P <0,05). En CA1 y CA3, a pesar de la
administración preventiva, sólo el tratamiento de ratas diabéticas con U. dioica aumentó significativamente los astrocitos. Este
estudio mostró que el tratamiento con extracto de U. dioica puede ayudar a compensar los astrocitos de los subcampos CA1 y CA3
del hipocampo en ratas diabéticas.
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